APOE and Alzheimer disease: Also, in the APOE ε4 heterozygotes, the HRs of PPI users were 1.55 (95% CI, 1.12–2.15; P = 0.008) and 1.80 (95% CI, 1.21–2.68; P = 0.004) for incident AD and VaD, respectively.